Health insurance should cover medical marijuana, Massachusetts gubernatorial candidate Jay Gonzalez says

To address the extreme toll of opioid addiction, Democratic candidate for governor Jay Gonzalez on Tuesday said he would require health insurers and the state’s MassHealth program to cover the cost of medical marijuana when it is prescribed by a physician for someone suffering from addiction.

“The point here is we’ve got to be bold about taking on this crisis and trying some new things,” Gonzalez told the News Service.

A total of 1,977 people in Massachusetts died of suspected or confirmed opioid overdoses in 2017, and the addiction crisis claimed 2,155 lives in 2016.

Opioid overdose emergency room visits up 30 percent nationwide

A former health insurance executive, Gonzalez said medical marijuana coverage was not an option for enrollees at CeltiCare Health, where he was CEO, because the insurer primarily covered MassHealth patients whose benefits were not discretionary.

State law features a list of conditions that can make patients eligible for medical marijuana, and Gonzalez said that while doctors could approve marijuana under a catch-all provision covering debilitating conditions, “what I am proposing is that it be explicitly listed as permissible.”

Under his proposal, medical marijuana insurance coverage would not extend to people already okayed to use the drug to treat non-addiction conditions.

Studies published by the American Medical Association from the University of Georgia, Athens and the University of Kentucky and Emory University, that found “letting people legally access marijuana appears to reduce reliance on addictive opioids.”

Gonzalez also declared his support for safe injection facilities, which are illegal but have drawn interest from some state lawmakers as a way to steer addicts into treatment and reduce overdose deaths. Under pending bills, individuals could use illegal drugs at facilities staffed by health care professionals. Gov. Charlie Baker has said he remains unconvinced of the efficacy of safe injection sites.

If

Bookmark the permalink.